Clinical Trial Update: Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating prasugrel switching in ACS patients who underwent PCI; study completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | Conditions: Acute Coronary Syndrome (ACS) | Phase 4 | Status: COMPLETED | Results posted: 2021-11-12